Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04255368 · ClinicalTrials.gov registry record · NA
Choline Source, Gut Microbiota and Trimethylamine-N-oxide Response
A NA study, sponsored by Utah State University.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT04255368 is a NA study that has completed, run by Utah State University. The registered enrollment target is 44 participants.
The verdict
NCT04255368, a NA study, has completed, sponsored by Utah State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
The purpose of this research is to determine the production of trimethylamine-N-oxide (TMAO) from different forms of choline and whether this response is modified by the gut microbiota composition.
Interventions
- OTHER Water-soluble choline
- OTHER Fat-soluble choline
- OTHER No choline control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2017-11-09 |
| Est. Completion | 2020-07-25 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04255368
The ClinicalTrials.gov registry entry for NCT04255368 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Utah State University, which has 27 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Water-soluble choline is the first listed.
NCT04255368 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04255368 about?
NCT04255368 is a clinical study titled "Choline Source, Gut Microbiota and Trimethylamine-N-oxide Response". The purpose of this research is to determine the production of trimethylamine-N-oxide (TMAO) from different forms of choline and whether this response is modified by the gut microbiota composition.
What is the current status of trial NCT04255368?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2017-11-09. Estimated completion is 2020-07-25.
What interventions are being tested in trial NCT04255368?
The interventions under investigation include: Water-soluble choline (OTHER), Fat-soluble choline (OTHER), No choline control (OTHER).
Who is sponsoring clinical trial NCT04255368?
This trial is sponsored by Utah State University, which has 27 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.